SC
ABBV icon

Sepio Capital’s AbbVie ABBV Stock Holding History

Sepio Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8M Sell
130,177
-6,551
-5% -$1.41M 1.65% 6
2026
Q1 		$29.7M Buy
136,728
+10,813
+9% +$2.4M 1.61% 7
2025
Q4 		$28.8M Sell
125,915
-9,074
-7% -$2.07M 1.57% 10
2025
Q3 		$31.3M Sell
134,989
-74,746
-36% -$15.2M 1.85% 8
2025
Q2 		$38.9M Sell
209,735
-19,432
-8% -$3.61M 2.77% 5
2025
Q1 		$48M Buy
229,167
+61,794
+37% +$12M 3.8% 4
2024
Q4 		$29.7M Sell
167,373
-38,086
-19% -$7M 2.38% 6
2024
Q3 		$40.6M Buy
205,459
+72,207
+54% +$13.5M 3.16% 4
2024
Q2 		$22.9M Sell
133,252
-27,995
-17% -$4.64M 2.1% 7
2024
Q1 		$29.4M Sell
161,247
-1,544
-0.9% -$266K 2.52% 5
2023
Q4 		$25.2M Sell
162,791
-17,328
-10% -$2.53M 2.12% 6
2023
Q3 		$26.8M Sell
180,119
-23,033
-11% -$3.38M 2.32% 5
2023
Q2 		$27.4M Buy
203,152
+42,715
+27% +$6.26M 2.22% 4
2023
Q1 		$25.6M Sell
160,437
-37,732
-19% -$5.77M 2.36% 3
2022
Q4 		$32M Sell
198,169
-31,522
-14% -$4.83M 2.77% 5
2022
Q3 		$30.8M Buy
229,691
+128,412
+127% +$18.4M 3.06% 5
2022
Q2 		$15.5M Buy
101,279
+77,950
+334% +$11.9M 1.56% 8
2022
Q1 		$3.78M Sell
23,329
-3,895
-14% -$566K 0.33% 93
2021
Q4 		$3.69M Buy
+27,224
New +$3.22M 0.27% 110
2019
Q1 		– Sell
-1,371,271
Closed -$126M – 218
2018
Q4 		$126M Buy
+1,371,271
New +$121M 9.19% 2

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Sepio Capital's ABBV Position: Q2 2026 in Review

Sepio Capital reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $1.41M and leaving 130,177 shares worth $32.8M. The position accounts for 1.65% of the portfolio, ranked #6.

Sepio Capital first reported a position in ABBV in Q4 2018 and has held it in 20 quarters since. The position peaked at $126M in Q4 2018. 2,085 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sepio Capital held 130,177 shares of AbbVie worth $32.8M as of Q2 2026.
  • Sepio Capital sold 6,551 AbbVie shares in Q2 2026, an estimated $1.41M.
  • AbbVie made up 1.65% of Sepio Capital's portfolio in Q2 2026, its #6 holding.
  • Sepio Capital first reported a position in AbbVie in Q4 2018 and has held it in 20 quarters since.
  • Sepio Capital's AbbVie position peaked at $126M in Q4 2018.
  • 2,085 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.